0% found this document useful (0 votes)
17 views16 pages

Cervical Cancer

Uploaded by

Nanda
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
17 views16 pages

Cervical Cancer

Uploaded by

Nanda
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 16

PLOS ONE

RESEARCH ARTICLE

Comparison of the complications between


minimally invasive surgery and open surgical
treatments for early-stage cervical cancer: A
systematic review and meta-analysis
Yilin Li1,2☯, Qingduo Kong1,2☯, Hongyi Wei2, Yongjun Wang ID2*

1 Clinical Medical College, Weifang Medical University, Weicheng District, Weifang, Shandong, China,
2 Division of Gynecology and Obstetrics, Life Science Park of Zhongguancun, Peking University International
a1111111111 Hospital, Changping District, Beijing, China
a1111111111
a1111111111 ☯ These authors contributed equally to this work.
a1111111111 * wyongjunhys@sina.com
a1111111111

Abstract

OPEN ACCESS
Background
Citation: Li Y, Kong Q, Wei H, Wang Y (2021)
Comparison of the complications between This meta-analysis comprehensively compared intraoperative and postoperative complica-
minimally invasive surgery and open surgical tions between minimally invasive surgery (MIS) and laparotomy in the management of cervi-
treatments for early-stage cervical cancer: A cal cancer. Even though the advantages of laparotomy over MIS in disease-free survival
systematic review and meta-analysis. PLoS ONE
16(7): e0253143. https://doi.org/10.1371/journal.
and overall survival for management of gynecological diseases have been cited in the litera-
pone.0253143 ture, there is a lack of substantial evidence of the advantage of one surgical modality over
Editor: Antonio Simone Laganà, University of
another, and it is uncertain whether MIS is justifiable in terms of safety and efficacy.
Insubria, ITALY

Received: November 6, 2020 Methods


Accepted: May 29, 2021 In this meta-analysis, the studies were abstracted that the outcomes of complications to
compare MIS (laparoscopic or robot-assisted) and open radical hysterectomy in patients
Published: July 1, 2021
with early-stage (International Federation of Gynecology and Obstetrics classification stage
Peer Review History: PLOS recognizes the
IA1-IIB) cervical cancer. The primary outcomes were intraoperative overall complications,
benefits of transparency in the peer review
process; therefore, we enable the publication of as well as postoperative aggregate complications. Secondary outcomes included the indi-
all of the content of peer review and author vidual complications. Two investigators independently performed the screening and data
responses alongside final, published articles. The extraction. All articles that met the eligibility criteria were included in this meta-analysis.
editorial history of this article is available here:
https://doi.org/10.1371/journal.pone.0253143
Results
Copyright: © 2021 Li et al. This is an open access
article distributed under the terms of the Creative The meta-analysis finally included 39 non-randomized studies and 1 randomized controlled
Commons Attribution License, which permits trial (8 studies were conducted on robotic radical hysterectomy (RRH) vs open radical hys-
unrestricted use, distribution, and reproduction in
terectomy (ORH), 27 studies were conducted on laparoscopic radical hysterectomy (LRH)
any medium, provided the original author and
source are credited. vs ORH, and 5 studies were conducted on all three approaches). Pooled analyses showed
that MIS was associated with higher risk of intraoperative overall complications (OR = 1.41,
Data Availability Statement: All relevant data are
within the paper and its Supporting Information 95% CI = 1.07–1.86, P<0.05) in comparison with ORH. However, compared to ORH, MIS
files. was associated with significantly lower risk of postoperative aggregate complications (OR =

PLOS ONE | https://doi.org/10.1371/journal.pone.0253143 July 1, 2021 1 / 16


PLOS ONE Complications of surgical treatments for early-stage cervical cancer

Funding: This article was funded by “Capital’s 0.40, 95% CI = 0.34–0.48, P = 0.0143). In terms of individual complications, MIS appeared
Funds for Health Improvement and Research” to have a positive effect in decreasing the complications of transfusion, wound infection, pel-
(2020-2-8022). The funders had no role in study
design, data collection and analysis, decision to
vic infection and abscess, lymphedema, intestinal obstruction, pulmonary embolism, deep
publish, or preparation of the manuscript. vein thrombosis, and urinary tract infection. Furthermore, MIS had a negative effect in
Competing interests: The authors have declared
increasing the complications of cystotomy, bowel injury, subcutaneous emphysema, and
that no competing interests exist. fistula.

Conclusions
Our meta-analysis demonstrates that MIS is superior to laparotomy, with fewer postopera-
tive overall complications (wound infection, pelvic infection and abscess, lymphedema,
intestinal obstruction, pulmonary embolism, and urinary tract infection). However, MIS is
associated with a higher risk of intraoperative aggregate complications (cystotomy, bowel
injury, and subcutaneous emphysema) and postoperative fistula complications.

1. Introduction
Being the fourth most common cancer among women, it has been estimated that there were
approximately 528, 000 new cases of cervical cancer with 266, 000 deaths annually [1]. Until
now, radical hysterectomy with an open abdominal approach was the predominant modality
for the treatment of early cervical cancer [2]. After 1992, with the development of laparoscopic
approach, minimally invasive surgery (MIS, i.e., laparoscopy or robotic surgery) for radical
hysterectomy to treat cervical cancer has been accepted widely as a standard treatment for
early-stage cervical cancer [3].
Surprisingly, the results of Laparoscopic Approach of the Cervix (LACC) clinical trial
showed that minimally invasive radical hysterectomy was associated with lower rates of dis-
ease-free survival and overall survival compared with open surgery in 2018 [4]. After that, the
open abdominal approach was defined as the “standard and recommended approach to radical
hysterectomy” for cervical cancer by the National Comprehensive Cancer Network (NCCN)
guidelines [5]. Therefore, discussing the surgical complications have to be done clarifying bet-
ter the actual role of MIS and laparotomy in cervical cancer.
Till date, the advantages of MIS over laparotomy for management of gynecological diseases
have been cited in the literature to included less blood loss, shorter hospital stay, and faster
recovery [6–8]. Similarly, most previous studies on this subject also showed that robotic sur-
gery has the advantages of providing a three-dimensional perspective and more accurate surgi-
cal positioning than laparotomy [9–11]. However, MIS was also associated with its complexity
of operation, longer learning curve, and higher cost than laparotomy. Therefore, there is no
good evidence of the overall advantage of one surgical modality over another, and it is uncer-
tain whether MIS is justifiable in terms of safety and efficacy, due to the small sample sizes, the
low-quality of previous studies, and the limited number of randomized controlled trials
(RCTs).
As for complications, many previous studies showed that MIS and open radical hysterec-
tomy (ORH) have no difference in terms of intraoperative and postoperative complications
[12]. With further development of instruments and skills, several studies found that MIS was
associated with lower rate of intraoperative and postoperative complications than laparotomy
[13]. Unfortunately, till date, it is unclear whether the rates of individual complications in MIS

PLOS ONE | https://doi.org/10.1371/journal.pone.0253143 July 1, 2021 2 / 16


PLOS ONE Complications of surgical treatments for early-stage cervical cancer

are also less than what are seen in laparotomy. Further emphasizing the severity of complica-
tions, which are a key factor in the evaluation of cervical cancer.
The aim of this meta-analysis was to compare the published rates of common intraoperative
and postoperative complications between ORH and MIS in order to provide valid evidence for
evaluating the advantages of different surgical procedures for managing cervical cancer.

2. Methods
2.1. Search strategy
A comprehensive, systemic search for articles was performed using the databases of PubMed,
Embase, Cochrane library, and Web of science. We searched the articles in each database from
the data of its inception until—February 2020. Search terms included a combination of syno-
nyms and abbreviations relating to cervical cancer, laparoscopy, laparotomy, robotic surgery,
and complication. All articles that met the eligibility criteria were assessed. The details of the
search strategy are shown in S1 Table.

2.2. Selection criteria


Studies were included if they met the following criteria: (1) Patients were classified as stage
IA-IIB (according to the 2018 International Federation of Gynecology and Obstetrics classifi-
cation); (2) Subjects were females who underwent LRH, laparoscopic-assisted vaginal radical
hysterectomy (LAVRH), RAH or ORH as primary treatment for cervical cancer; (3) The out-
comes of complications in MIS and ORH were reported. Articles were excluded if they met the
following criteria: (1) Patients received other treatments (radiation or concurrent chemoradia-
tion therapy) before surgery; (2) The articles were case reports, reviews, meta-analysis, organi-
zational guidelines, letters, expert opinions, or conference abstracts; (3) The studies had
inadequate data for outcome assessment; (4) The articles had no outcomes of interest. (5) The
published Articles were not in English.

2.3. Data extraction and quality assessment


Data were extracted into a standard form, and included information on the first author, publi-
cation year, country, participants’ characteristics, study design, number of study participants,
surgical approaches, and FIGO stage. Primary outcomes were intraoperative total complica-
tions and postoperative aggregate complication. Secondary outcomes were categorized into
two groups (individual intraoperative and postoperative complications). Individual intrao-
perative complications included bladder damage, cystotomy, bowel injury, subcutaneous
emphysema, nerve injury, ureteral injury, and vessel injury. Postoperative complications
included wound infection, incisional hernia, pelvic infection and abscess, lymphedema, lym-
phocyst, intestinal obstruction, pulmonary embolism, deep vein thrombosis, and fistula. In
this meta-analysis, we used the Newcastle-Ottawa scale to evaluate 39 studies and the Jadad
scale to evaluate 1 study S2 and S3 Tables [14, 15]. Two reviewers independently evaluated and
cross-checked the qualities of the included studies, as well as assessed the bias of the studies.
Disagreements were discussed between two evaluators in order to reach a consensus and the
third reviewer also provided the opinion.

2.4. Data synthesis and meta-analysis


This meta-analysis was conducted using Stata SE version 12.0 software (StataCorp, College
Station, TX). We analyzed heterogeneity with the chi-square test, and P-value < 0.10 was used
to establish statistical significance with I2 test [16]. I2 values > 50% were considered substantial

PLOS ONE | https://doi.org/10.1371/journal.pone.0253143 July 1, 2021 3 / 16


PLOS ONE Complications of surgical treatments for early-stage cervical cancer

evidence of statistical heterogeneity. To estimate pooled odds ratio (OR) with 95% confidence
interval (CI), a fixed-effects model was used in the absence of significant heterogeneity; the
random-effects model was used in the presence of significant heterogeneity [17]. We evaluated
the publication bias for each of the pooled study groups with a funnel plot. We carried out sub-
group analysis based on the modalities of MIS (LAVRH, total laparoscopic radical hysterec-
tomy (TLRH), and RRH) to assess the outcomes of different subgroups.

3. Results
A total of 40 studies were included in this analysis. The flowchart of the selection process is
shown in Fig 1. The initial search retrieved 3,673 articles from the four databases. All articles
were imported into Endnote for screening. After excluding duplicates, 1,887 articles were
identified for the next step of screening. By reviewing titles and abstracts, 1,798 articles were
removed for not meeting the selection criteria, and 89 articles were identified to be assessed
for eligibility. Eventually, 40 studies were identified in the final analysis, and all of them were
screened after reviewing the full text. We used the Newcastle-Ottawa scale to assess the quality
of 39 studies and Jadad scale to assess 1 RCT, Table 1 shows the results of included studies.
The main characteristics of the 40 studies are shown in Table 1. The study designs were as
follow: retrospective study (n = 31) [18–48], retrospective matched study (n = 6) [49–54], pro-
spective cohort study (n = 2) [55, 56], and RCT (n = 1) [57]. Thirteen studies were conducted
in Asia (China, Israel, Korea, Singapore, and Taiwan) [21, 35, 36, 38, 39, 41, 42, 45, 47, 52, 54–

Fig 1. Flow chart of study selection in this meta-analysis.


https://doi.org/10.1371/journal.pone.0253143.g001

PLOS ONE | https://doi.org/10.1371/journal.pone.0253143 July 1, 2021 4 / 16


PLOS ONE Complications of surgical treatments for early-stage cervical cancer

Table 1. Characteristics of the 40 studies included in the meta-analysis.


Study cohort Year Country Study design Approach Number(N) FIGO stage (N) BMIa Agea(years) Scoreb
Lee et al. 2002 China, Taiwan prospective LAVRH 30 IA-IB 30 54.4 ± 12.6 46.2(32–64) 6
ORH 30 IA-IB 30 56.3 ± 10.4 48.0(34–68)
Steed et al. 2004 Canada retrospective LAVRH 71 IA-IB 71 - 43 (30–69) 6
ORH 205 IA-IB 205 - 44 (24–86)
Sharma et al. 2006 England retrospective LAVRH 35 IA2–IIB 35 - 43.4(28–60) 8
ORH 32 IA2–IIB 32 - 42.8(28–66)
Frumovitz et al. 2007 USA retrospective LRH 35 IA-IB 35 28.1(18.4–40.8) 40.8(28.4–63.4) 8
ORH 54 IA-IB 54 28.2(17.4–46.4) 42.5(27.3–68.3)
Li et al. 2007 China retrospective LRH 90 IB-IIA 90 - 42 ± 9 6
ORH 35 IB-IIA 35 - 44 ± 11
Morgan et al. 2007 Ireland retrospective matched LAVRH 30 IA–IB 30 25 (18.6–47) 35 (25–54) 6
ORH 30 IA–IIB 30 24 (19.8–29.5) 38 (20–63)
Uccella et al. 2007 Italy retrospective LRH 50 IA2–IIA 50 23 (17.4–35) 47 (24–78) 7
ORH 48 IA2–IIA 48 25 (19–43) 53 (28–75)
Zakashansky et al. 2007 USA retrospective matched LRH 30 IA1–IIA 30 - 48.3 ± 12.25 7
ORH 30 IA1–IIA 30 - 46.6 ± 11.75
Boggess et al.c 2008 USA retrospective RRH 51 IA1–IIA 47 28.6 ± 7.2 47.4 ± 12.9 6
ORH 49 IA2–IIA 49 26.1 ± 5.1 41.9 ± 11.2
Ko et al. 2008 USA retrospective RRH 16 IA1–IB1 16 27.6 ± 6.4 42.3 ± 7.9 5
ORH 32 IA1–IIA 32 26.6 ± 5.9 41.7 ± 8.1
Estape et al. 2009 USA retrospective RRH 32 IB1-IB2 32 29.7 ± 3.2 55.0(33–83) 7
LRH 17 IA2-IB2 17 28.1 ± 4.8 52.8(37–83)
ORH 14 IB1-IB2 14 29.5 ± 6.4 42.0(27–71)
Maggioni et al. 2009 USA retrospective RRH 40 IA2–IIA 40 24.1 ± 5.5 44.1 ± 9.1 7
ORH 40 IA2–IIA 40 23.6 ± 5.0 49.8 ± 14.1
Malzoni et al. 2009 Italy retrospective TLRH 65 IA1–IB1 65 26(19–35) 40.5 ± 7.7 9
ORH 62 IA1–IB1 62 29(19–35) 42.7 ± 8.6
Papacharalabous et al. 2009 UK retrospective LAVRH 14 IA2–IB 14 - 38.6 ± 3.6 8
ORH 12 IA2–IB 12 - 43.5 ± 12.9
Sobiczewski et al. 2009 Poland retrospective LRH 22 IA1–IB1 22 - 45.44 ± 9 8
ORH 58 IA1–IIA 58 - 51.19 ± 12
Schreuder et al. c 2010 Netherlands retrospective RRH 13 IB1-IIB 13 - 43 (31–78) 7
ORH 14 IB1-IB2 14 - 46 (32–68)
Lee et al. 2011 ROK retrospective LRH 24 IA2–IIa 24 23.4±3.55 48.4 ± 7.25 9
ORH 48 IA2–IIa 48 23.9±4.7 50.2 ± 8.25
Sert et al. 2011 Norway retrospective RRH 35 IA1–IB1 35 25.4±4.36 44.1 ± 10.5 9
LRH 7 IA1–IB1 7 22.5±1.84 45.0 ± 12.9
ORH 26 IA1–IB1 26 25±3.0 44.8 ± 11.8
Taylor et al. 2011 USA retrospective LAVRH 9 IA2–IB1 9 26.3 (20.6–36.1) 41.4 (31–60) 7
ORH 18 IA2–IB1 18 26.9 (17–38.3) 41.1 (25–61)
Gortchev et al. 2012 Bulgaria retrospective RRH 73 - - 46.0 ± 11.2 8
LAVRH 46 - - 42.5 ± 9.9
ORH 175 - - 49.0 ± 11.0
Nam et al. 2012 Korea retrospective matched LRH 263 IA2–IIA 263 - - 8
ORH 263 IA2–IIA 263 - -
Park et al. 2012 Korea retrospective LRH 54 IA2–IIA2 54 31.8 ± 1.39 49.4 ± 11.5 7
ORH 112 IA2–IIA2 112 31.7 ± 1.5 52.1 ± 11.8
(Continued )

PLOS ONE | https://doi.org/10.1371/journal.pone.0253143 July 1, 2021 5 / 16


PLOS ONE Complications of surgical treatments for early-stage cervical cancer

Table 1. (Continued)

Study cohort Year Country Study design Approach Number(N) FIGO stage (N) BMIa Agea(years) Scoreb
Lim et al. 2013 Singapore prospective LRH 18 IA1-IIA 18 22.9 (16.0–33.7) 48 (30–65) 9
ORH 30 IA1-IIA 30 22.4 (17.9–33.9) 47 (33–67)
Park et al. 2013 Korea retrospective LRH 115 IB2-IIA2 115 23.1 (15.6–34.8) 48.5 (25–77) 8
ORH 188 IB2-IIA2 188 23.7 (17.6–34.7) 48.1 (25–84)
BoganI et al. 2014 Italy retrospective LRH 65 IA2-IIB 65 25.1 ± 5.2 48.9 ±13.5 9
ORH 65 IA2-IIB 65 25.9 ± 6.1 50.9 ± 14
Chen et al. 2014 Taiwan retrospective RRH 24 IA-IIB 24 24.4 ± 4.9 53.7 ± 15.3 8
LRH 32 IA-IIB 32 23.2 ± 3.4 51.2 ± 11.9
ORH 44 IA-IIB 44 24.9 ± 4.6 51.9 ± 11.3
Yin et al. 2014 China retrospective LRH 22 IA2–IIA 22 - 44 ± 1.5 6
ORH 23 IA2–IIA 23 - 46 ± 2.3
Asciutto et al. 2015 Sweden retrospective RRH 64 IA2–IIA 64 27.0 ± 6.1 45.4 ± 13.6 6
ORH 185 IA2–IIA 178 25.7 ± 4.7 45.7 ± 13.0
Ditto et al. 2015 Italy retrospective matched LRH 60 IA2–IB1 60 24.3 ± 2.9 46 (29–79) 9
ORH 60 IA2–IB1 60 24.0 ± 4.3 45.5 (15–78)
Xiao et al. 2015 China retrospective LRH 106 IA-IIB 106 23.8 ± 3.9 43.7 ± 9.3 8
ORH 48 IA-IIB 48 24.7 ± 3.8 45.7 ± 11.3
Park et al. 2016 Korea retrospective LRH 186 IA2–IIA1 186 23.69 (17.1–34.9) 45.3 (27–71) 7
ORH 107 IA2–IIA1 107 23.58 (17.1–35.9) 47.3 (28–73)
Shah et al. 2017 USA retrospective RRH 109 IA1-IB2 109 27.9 (17.6–51.6) 45.2 (25–84) 7
ORH 202 IA1-IB2 202 29.1 (18.3–55.7) 45.4 (19–88)
Corrado et al. 2018 Italy retrospective RRH 88 IB1 88 23.3 (18–47.6) 46 (27–77) 8
LRH 152 IB1 152 23.5 (17–35) 45 (23–78)
ORH 101 IB1 101 24.8 (18–51) 50 (28–76)
Guo et al. 2018 China retrospective LRH 412 IA-IIA 412 22.81 (14.3–35.6) 44.19 (25–76) 7
ORH 139 IA-IIA 139 23.19 (13.8–36.6) 40.52 (23–62)
Bogani et al. c 2019 Italy Retrospective matched LRH 35 IB1-IIA 23 22.9 ± 4.0 41.1 ± 6.9 7
ORH 35 IB1-IIA 24 20.1 ± 9.3 44.1 ± 12.7
Matanes et al. 2019 Israel retrospective RRH 74 IA1-IIA 74 26.4(18.2–42.1) 48(29–77) 8
ORH 24 IA1-IIA 24 26.2(20.6–38.5) 47(24–69)
Piedimonte et al. 2019 Canada Retrospective RRH 749 - - - 6
ORH 2584 - - -
Yuan et al. 2019 China Retrospective matched LRH 99 IIA2-IIA2 99 44.56 ± 7.60 43.58 ± 8.86 9
ORH 99 IIA2-IIA2 99 24.56 ± 1.50 44.56 ± 7.60
Pahisa et al. 2010 Spain Retrospective LAVRH 67 IA2-IIA 67 25.4 ± 1.1 51 (29–75) 7
ORH 23 IA2-IIA 23 27.2 ± 2.5 48 (31–67)
Campos et al. 2013 Brazil RCT LRH 16 IA2–IB 16 - 36.19 ± 9.78 5
ORH 14 IA2–IB 14 - 39.64 ± 6.23

ORH: Open radical hysterectomy, LRH: Laparoscopic radical hysterectomy, RRH: Robotic radical hysterectomy, LAVRH: Laparoscopic-assisted vaginal radical
hysterectomy, RCT: Randomized controlled trial
a: Mean, median or unknow.
b: Jadad scale: score: 1~3, indicating low quality study; score: 4~7, indicating high quality study. Newcastle-Ottawa scale: score�5, indicating high risk of bias; score>5,
indicating low risk of bias.
c: These studies including other FIGO stages of cervical cancer.

https://doi.org/10.1371/journal.pone.0253143.t001

PLOS ONE | https://doi.org/10.1371/journal.pone.0253143 July 1, 2021 6 / 16


PLOS ONE Complications of surgical treatments for early-stage cervical cancer

56], ten in North America (Canada, and USA) [18, 20, 23–26, 33, 43, 48, 51], sixteen in Europe
(UK, Ireland, Poland, Netherlands, Federal Republic of Germany, Norway, Bulgaria, Italy,
Sweden, and Spain) [19, 22, 27–32, 34, 37, 40, 44, 46, 49, 50, 53], and one study in South Amer-
ica (Brazil) [57]. In all, we identified 9003 patients in the pooled analysis: 2277 patients had
LRH, 1,368 patients had RRH and 5358 patients had ORH (we compared 1,368 patients who
underwent RRH vs 3,490 patients who underwent ORH, and 2277 patients who underwent
LRH vs 2,228 patients who underwent ORH). As shown in Table 1, 8 studies compared RRH
with ORH [23, 24, 26, 29, 39, 42, 46, 47], 25 studies compared LRH with ORH [18–22, 27, 28,
30, 32, 34–36, 38, 40, 41, 44, 45, 48–57], and 5 studies compared all 3 surgical approaches [25,
31, 33, 37, 43].

3.1 MIS vs ORH


3.1.1 Primary outcomes. We show the results of intraoperative aggregate complications
and postoperative overall complications between MIS and ORH in Fig 2, respectively. For
intraoperative complications, the incidence of intraoperative complications in MIS (121/3459)
were statistically higher than ORH (102/5174), and the risk of intraoperative complications
(OR = 1.41, 95% CI = 1.07–1.86, P<0.05) in MIS was higher compared with ORH. In terms of
postoperative complications, MIS was associated with significantly lower risk of postoperative
complications (OR = 0.40, 95% CI = 0.34–0.48, P = 0.0143) compared with ORH. There was
no heterogeneity in studies of intraoperative aggregate complications (I2 = 0%, P = 0.748).
However, we found that the studies of postoperative overall complications were associated
with high heterogeneity (I2 = 51%, P<0.01). The result of publication bias was shown in Fig 3,
the funnel plot was nearly symmetric on both sides, so there was no publication bias in the
results of intraoperative aggregate complications and postoperative overall complications.
3.1.2 Secondary outcomes. In order to determine the source of difference, we analyzed
the results of individual intraoperative and postoperative complications in Table 2, respec-
tively. For intraoperative complications, there were no significant differences between MIS
and ORH in the bladder damage, nerve injury, ureteral injury, or vessel injury, with ORs of
1.28 (95% CI = 0.75–2.19, P = 0.3), 0.51 (95% CI = 0.14–1.93, P = 0.343), 1.05 (95% CI = 0.61–
1.76, P = 0.959), 1.01 (95% CI = 0.59–1.73, P = 0.753), respectively. However, MIS was associ-
ated with increased risk of cystotomy (OR = 2.27, 95% CI = 1.23–4.20), bowel injury
(OR = 2.15, 95% CI = 0.95–4.89), subcutaneous emphysema (OR = 4.36, 95% CI = 0.94–20.29)
in comparison with ORH. In terms of postoperative complications, there were comparable in
the risk of incisional hernia (OR = 0.93, 95% CI = 0.34–2.51, P = 0.803) and lymphocyst
(OR = 0.73, 95% CI = 0.46–1.15, P = 0.123) between MIS and ORH. Comparing to ORH, MIS
was associated with significantly lower risks of wound-infection (OR = 0.15, 95% CI = 0.08–
0.28, P<0.01), pelvic infection and abscess (OR = 0.40, 95% CI = 0.26–0.63, P<0.01), lymph-
edema (OR = 0.48, 95% CI = 0.24–0.98, P = 0.03), intestinal obstruction (OR = 0.30, 95%
CI = 0.21–0.43, P<0.01), pulmonary embolism (OR = 0.36, 95% CI = 0.09–1.48, P = 0.025),
deep vein thrombosis (OR = 0.56, 95% CI = 0.35–0.88, P = 0.01), and urinary tract infection
(OR = 0.56, 95% CI = 0.34–0.91, P = 0.013). However, the risk of fistula (OR = 1.69, 95%
CI = 0.02–2.79, P = 0.011) was significant increased in the MIS group than in ORH.

3.2 Subgroup analysis


The subgroup analysis compared intraoperative complications and postoperative complica-
tions among the three types of MIS, as shown in Table 3. For intraoperative aggregate compli-
cations, compared to ORH, the risks of complications were not increased in RRH (OR = 1.11,
95% CI = 0.62–2.01, P = 0.11) and TLRH (OR = 1.34, 95%CI = 0.94–1.93, P = 0.722), whereas

PLOS ONE | https://doi.org/10.1371/journal.pone.0253143 July 1, 2021 7 / 16


PLOS ONE Complications of surgical treatments for early-stage cervical cancer

PLOS ONE | https://doi.org/10.1371/journal.pone.0253143 July 1, 2021 8 / 16


PLOS ONE Complications of surgical treatments for early-stage cervical cancer

Fig 2. Forest plots of intraoperative and postoperative complications between Minimally Invasive Surgical (MIS)
and Open Radical Hysterectomy (ORH). OR, odds ratio.
https://doi.org/10.1371/journal.pone.0253143.g002

it was higher in LAVRH (OR = 2.27, 95%CI = 1.02–5.04, P = 0.044). For postoperative overall
complication, the risk in LAVRH (OR = 0.71, 95%CI = 0.26–1.93, P = 0.506) was not statisti-
cally different from that of ORH. However, RRH (OR = 0.42, 95%CI = 0.26–0.68, P<0.01) and
TLRH (OR = 0.58, 95%CI = 0.45–0.74, P<0.01) was associated with a reduced risk of postop-
erative complication when compared with ORH. In a stratified analysis (S4 Table), in an
attempt to further determine the difference in fistula complications, we also analyzed compli-
cations with different types of fistula, including vesicovaginal, rectovaginal, ureterovaginal and
urinary fistula, with ORs of 1.55 (95%CI = 0.59–4.06, P = 0.376), 2.88 (95%CI = 0.44–18.70,
P = 0.269), 1.60 (95%CI = 0.59–4.34, P = 0.353), and 1.25 (95%CI = 0.53–2.97, P = 0.612)
respectively. Interestingly, there was no significant difference in risk of the individual fistula
types between MIS and ORH.

4. Discussion
This study assessed most comprehensive results of complications of cervical cancer surgeries
and evaluated the safety of different surgical strategies. The rates of perioperative complica-
tions will become a key factor of importance in comparing surgical modalities for managing
cervical cancer. We aimed to provide a basis for the selection of optimal surgical methods, as
well as offer new opinions for actual role of MIS in cervical cancer.
Our meta-analysis indicated that the overall risk of intraoperative complications was
increased with MIS than with ORH. Patients accepted to MIS experienced almost 2 times the
risk of intraoperative complications compared with patients accepted to ORH. There were no
significant differences in risk for intraoperative complications including bladder damage,
nerve injury, ureteral injury, and vessel injury among individual intraoperative complications.
However, MIS group was associated with higher risk in complications of cystotomy, bowel
injury, and subcutaneous emphysema in comparison to ORH. This finding was consistent
with previous studies. The differences in bowel injury between MIS and ORH can be explained
by the use of surgical instruments such as a trocar and Veress needle during radical hysterec-
tomy. Previous studies have shown that the majority of bowel injuries occurred during lapa-
roscopy using a Veress needle or trocar placement [58, 59]. The subcutaneous emphysema was
the unique complications in MIS, many risk factors will lead to it during MIS including
increased intra-abdominal pressure, total gas volume, and gas flow rate [60].

Fig 3. Funnel plot of studies evaluating the publication bias of intraoperative and intraoperative complications
between MIS and ORH. (A). intraoperative complications. (B). postoperative complications.
https://doi.org/10.1371/journal.pone.0253143.g003

PLOS ONE | https://doi.org/10.1371/journal.pone.0253143 July 1, 2021 9 / 16


PLOS ONE Complications of surgical treatments for early-stage cervical cancer

Table 2. Meta-analysis estimates of individual complications between MIS and ORH.


Category MIS ORH OR (95% CI) P value I2(%)
Transfusion 301/2490 494/4408 0.34[0.22,0.53] <0.001 72.3
Intraoperative complications
Bladder damage 25/2279 24/4009 1.28[0.75,2.19] 0.3 0
Cystotomy 32/586 14/677 2.27[1.23,4.20] 0.002 0
Bowel injury 12/1479 8/3449 2.15[0.95,4.89] 0.041 0
Subcutaneous emphysema 7/246 0/207 4.36[0.94,20.29] 0.008 0
Nerve injury 2/1181 5/802 0.51[0.14,1.93] 0.343 0
Ureteral injury 22/2519 24/4520 1.05[0.61,1.76] 0.959 0
Vessel injury 21/2328 27/4112 1.01[0.59,1.73] 0.753 0
Postoperative complications
Wound infection 5/1380 104/3277 0.15[0.08,0.28] <0.001 0
Incisional hernia 7/898 7/811 0.93[0.34,2.51] 0.803 0
Pelvic infection and abscess 30/1713 78/3396 0.40[0.26,0.63] <0.001 39.9
Lymphedema 13/791 19/619 0.48[0.24,0.98] 0.03 0
Lymphocyst 40/1614 35/1194 0.73[0.46,1.15] 0.123 8.4
Intestinal obstruction 37/2490 281/4070 0.30[0.21,0.43] <0.001 0
Pulmonary embolism 0/508 7/558 0.36[0.09,1.48] 0.025 0
Deep vein thrombosis 31/2289 78/3886 0.56[0.35,0.88] 0.01 0
Fistula 38/2203 17/1904 1.69[0.02,2.79] 0.011 0
Urinary tract infection 33/764 44/799 0.56[0.34,0.91] 0.013 3

OR: Odds ratio; CI: Confidence interval; MIS: Minimally invasive surgery; ORH: Open radical hysterectomy

https://doi.org/10.1371/journal.pone.0253143.t002

Regarding postoperative complications, our meta-analysis found that MIS was associated
with significantly lower risk of postoperative overall complications compared with ORH. In
individual postoperative complications, incisional hernia and lymphocyst had no differences
between MIS and ORH. MIS was superior to ORH in terms of wound infection, pelvic infec-
tion and abscess, lymphedema, intestinal obstruction, pulmonary embolism, and urinary tract
infection, whereas the risk of fistula complications was significantly increased, with MIS com-
pared to ORH. Interestingly, in a stratified analysis of fistula complications, we found that
there were no significant differences in risk for four types of fistula complications. Possible rea-
sons for this result including individual fistula complication had small sample size and

Table 3. The subgroup analysis of laparoscopic types between MIS and ORH in intraoperative and postoperative overall complications.
Category Laparoscopic type Study OR (95% CI) P value I2(%)
Intraoperative complications
TLRH 23 1.34[0.94,1.93] 0.11 0
LAVRH 5 2.27[1.02,5.04] 0.044 0
RRH 13 1.11[0.62,2.01] 0.722 0
Postoperative complications
TLRH 25 0.58[0.45,0.74] <0.01 0
LAVRH 7 0.71[0.26,1.93] 0.506 58.5
RRH 11 0.42[0.26,0.68] <0.01 45.3

OR: Odds ratio; CI: Confidence interval; TLRH: Total laparoscopic radical hysterectomy; RRH: Robotic radical hysterectomy; LARVH: Laparoscopic assisted
radical vaginal hysterectomy.

https://doi.org/10.1371/journal.pone.0253143.t003

PLOS ONE | https://doi.org/10.1371/journal.pone.0253143 July 1, 2021 10 / 16


PLOS ONE Complications of surgical treatments for early-stage cervical cancer

excessive weight of included studies biased the results [61]. Although there were no significant
differences in the risks of vesicovaginal, rectovaginal, ureterovaginal, and urinary fistula
between MIS and ORH, the incidence rates of these four types of fistula complications in MIS
were higher than that of ORH. This finding was worthy of our attention.
Taken together, the surgeon proficiency may be a factor in determining the rates of compli-
cations. Regrettably, this meta-analysis was not able to provide a comparison between sur-
geons. Furthermore, the learning curve could play an important role in complications between
different surgical modalities, and MIS was associated with a longer learning curve than ORH
because of the complexity of surgical procedure, and also might have influenced complication
rates [62, 63]. The use of surgical instruments was related to viscus injuries, which may be
caused by thermal injury, due to the high temperature of the surgical instruments resulting in
the damage of submucosal or deeper tissues of the bladder, intestines, and bowel. Previous
studies have evaluated the thermal injury of bowel in laparoscopic approach [62]. It must be
taken that thermal injury was an inherent risk of the technique during radical hysterectomy,
and therefore surgeon should pay attention to this issue. Overall, these factors were associated
with the incidence of intraoperative and postoperative complications.
Concerning the subgroup meta-analysis of surgical modalities, intraoperative complication
rate increased in the course of LAVRH, as well as there were no differences in TLRH and
RRH. This finding is consistent with that of previous meta-analyses. The requirement for
refinement of LAVRH is very high due to the complex pelvic floor anatomy in females. In the
vaginal approach, the ureters and bladder are identified by traction on the uterus after the liga-
ment around the uterus is isolated and cut [64], and urinary tract trauma is a clear risk during
LAVRH. With time, laparoscopy is continually evolving with the improvement in surgical
skills, instruments, and learning curve, and these improvements may be partly responsible for
reduction in intraoperative complication over time [63]. For postoperative aggregate compli-
cations, both RRH and TLRH were associated with lower risk compared to ORH. These results
were validated in previous studies, Park et al. compared the complications of three approaches,
RRH had a positive effect in reducing overall complications than ORH for cervical cancer
patients [65]. For LAVRH group, the high heterogeneity and the small sample size could bias
the results of postoperative complications. In the future, we need more high-quality cohort
studies to evaluate and compare the risk of postoperative complications between MIS and
ORH.
There are limitations to this meta-analysis. First, included studies were primarily non-ran-
domized studies, which could not provide high-quality evidence. Furthermore, our study did
not include single-arm studies, which can lead to the bias of the result. Additionally, differ-
ences in patients’ characteristics between different surgical cohorts may lead to highly hetero-
geneous outcomes in studies and affect the results of the pooled analysis. The statistical
methods could not fully diminish these differences. Second, the difference of surgeons in these
articles were not reported including the level of experience in surgeons and types of surgeons,
these factors could affect the surgical outcomes as time went by. The additional morbidities of
patients in these studies were not involved, these factors could contribute to the bias of results.
Third, most studies included in this meta-analysis did not use standardized methods of classi-
fying complications, such as the Clavien-Dindo classification system, and the final results may
be affected by these differences in the reporting of complications. Among all included studies,
only one adopted the Clavien-Dindo classification system of complications [39]. Forth, during
the extraction of complication data, many studies revealed that patients had undergone cesar-
ean section or previous abdominal surgery and had severe adhesions in the past, alluding to
the fact that the success of laparoscopy will be affected by adhesions. Therefore, the incidence
of complications ultimately may interfere with the results and may be a cause of bias.

PLOS ONE | https://doi.org/10.1371/journal.pone.0253143 July 1, 2021 11 / 16


PLOS ONE Complications of surgical treatments for early-stage cervical cancer

5. Conclusion
Our meta-analysis demonstrates that MIS is superior to laparotomy, with fewer postoperative
overall complications (wound infection, pelvic infection and abscess, lymphedema, intestinal
obstruction, pulmonary embolism, and urinary tract infection). However, MIS is associated
with a higher risk of intraoperative aggregate complications (cystotomy, bowel injury, and sub-
cutaneous emphysema) and postoperative fistula complications. In the future, high-quality
prospective studies and RCTs are needed to provide sufficient evidence for evaluating the pros
and cons of using MIS to treat cervical cancer.

Supporting information
S1 Checklist. PRISMA 2009 checklist.
(DOC)
S1 Fig. PRISMA 2009 flow diagram.
(DOC)
S1 Table. Detailed search strategy.
(DOC)
S2 Table. Quality assessment of the included studies according to modified NOS score.
(DOC)
S3 Table. Quality assessment of the included studies according to modified Jadad score.
(DOC)
S4 Table. The subgroup analysis of fistula types between MIS and ORH.
(DOC)

Author Contributions
Conceptualization: Yongjun Wang.
Data curation: Yilin Li.
Funding acquisition: Yongjun Wang.
Investigation: Qingduo Kong, Hongyi Wei.
Methodology: Yilin Li, Yongjun Wang.
Supervision: Hongyi Wei.
Visualization: Qingduo Kong.
Writing – original draft: Yilin Li.
Writing – review & editing: Yilin Li, Yongjun Wang.

References
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLO-
BOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J
Clin. 2018; 68(6):394–424. Epub 2018/09/13. https://doi.org/10.3322/caac.21492 PMID: 30207593.
2. Ries E. The operative treatment of cancer of the cervix. JAMA. 1906; XLVII(23):1869–1872. https://doi.
org/10.1001/jama.1906.25210230005001b
3. Wright JD, Herzog TJ, Neugut AI, Burke WM, Lu YS, Lewin SN, et al. Comparative effectiveness of min-
imally invasive and abdominal radical hysterectomy for cervical cancer. Gynecol Oncol. 2012 Oct; 127
(1):11–7. https://doi.org/10.1016/j.ygyno.2012.06.031 Epub 2012 Jun 24. PMID: 22735788.

PLOS ONE | https://doi.org/10.1371/journal.pone.0253143 July 1, 2021 12 / 16


PLOS ONE Complications of surgical treatments for early-stage cervical cancer

4. Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, et al. Minimally Invasive versus
Abdominal Radical Hysterectomy for Cervical Cancer. N Engl J Med. 2018; 379(20):1895–904. Epub
2018/11/01. https://doi.org/10.1056/NEJMoa1806395 PMID: 30380365.
5. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: cervical can-
cer version 1. Accessed April 1, 2020. https://www.nccn.org/professionals/physician_gls/pdf/cervical_
blocks.pdf.
6. Wang YZ, Deng L, Xu HC, Zhang Y, Liang ZQ. Laparoscopy versus laparotomy for the management of
early stage cervical cancer. BMC Cancer. 2015; 15:928. Epub 2015/11/26. https://doi.org/10.1186/
s12885-015-1818-4 PMID: 26596955.
7. Diver E, Hinchcliff E, Gockley A, Melamed A, Contrino L, Feldman S, et al. Minimally Invasive Radical
Hysterectomy for Cervical Cancer Is Associated With Reduced Morbidity and Similar Survival Out-
comes Compared With Laparotomy. J Minim Invasive Gynecol. 2017; 24(3):402–6. Epub 2016/12/25.
https://doi.org/10.1016/j.jmig.2016.12.005 PMID: 28011096.
8. Galaal K, Donkers H, Bryant A, Lopes AD. Laparoscopy versus laparotomy for the management of
early stage endometrial cancer. Cochrane Database Syst Rev. 2018; 10:CD006655. Epub 2018/11/01.
https://doi.org/10.1002/14651858.CD006655.pub3 PMID: 30379327.
9. Maenpaa MM, Nieminen K, Tomas EI, Laurila M, Luukkaala TH, Maenpaa JU. Robotic-assisted vs tra-
ditional laparoscopic surgery for endometrial cancer: a randomized controlled trial. Am J Obstet Gyne-
col. 2016; 215(5):588 e1- e7. Epub 2016/10/30. https://doi.org/10.1016/j.ajog.2016.06.005 PMID:
27288987.
10. Park DA, Yun JE, Kim SW, Lee SH. Surgical and clinical safety and effectiveness of robot-assisted lap-
aroscopic hysterectomy compared to conventional laparoscopy and laparotomy for cervical cancer: A
systematic review and meta-analysis. Eur J Surg Oncol. 2017; 43(6):994–1002. Epub 2016/08/23.
https://doi.org/10.1016/j.ejso.2016.07.017 PMID: 27546015.
11. Gala RB, Margulies R, Steinberg A, Murphy M, Lukban J, Jeppson P, et al. Systematic review of robotic
surgery in gynecology: robotic techniques compared with laparoscopy and laparotomy. J Minim Inva-
sive Gynecol. 2014; 21(3):353–61. Epub 2013/12/04. https://doi.org/10.1016/j.jmig.2013.11.010 PMID:
24295923.
12. Brandt B, Sioulas V, Basaran D, Kuhn T, LaVigne K, Gardner GJ, et al. Minimally invasive surgery ver-
sus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival out-
comes. Gynecol Oncol. 2020; 156(3):591–7. Epub 2020/01/11. https://doi.org/10.1016/j.ygyno.2019.
12.038 PMID: 31918996.
13. Obermair A, Asher R, Pareja R, Frumovitz M, Lopez A, Moretti-Marques R, et al. Incidence of adverse
events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a random-
ized controlled trial. Am J Obstet Gynecol. 2020; 222(3):249 e1- e10. Epub 2019/10/07. https://doi.org/
10.1016/j.ajog.2019.09.036 PMID: 31586602.
14. Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale
(NOS) for assessing the quality of nonrandomised studies in meta-analyses. (2000).
15. Clark HD, Wells GA, Huet C, McAlister FA, Salmi LR, Fergusson D, et al. Assessing the quality of ran-
domized trials: reliability of the Jadad scale. Control Clin Trials. 1999; 20(5):448–52. Epub 1999/09/30.
https://doi.org/10.1016/s0197-2456(99)00026-4 PMID: 10503804.
16. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21
(11):1539–58. Epub 2002/07/12. https://doi.org/10.1002/sim.1186 PMID: 12111919.
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ.
2003; 327(7414):557–60. Epub 2003/09/06. https://doi.org/10.1136/bmj.327.7414.557 PMID:
12958120.
18. Steed H, Rosen B, Murphy J, Laframboise S, De Petrillo D, Covens A. A comparison of laparascopic-
assisted radical vaginal hysterectomy and radical abdominal hysterectomy in the treatment of cervical
cancer. Gynecol Oncol. 2004; 93(3):588–93. Epub 2004/06/16. https://doi.org/10.1016/j.ygyno.2004.
04.003 PMID: 15196849.
19. Sharma R, Bailey J, Anderson R, Murdoch J. Laparoscopically assisted radical vaginal hysterectomy
(Coelio-Schauta): A comparison with open Wertheim/Meigs hysterectomy. Int J Gynecol Cancer. 2006;
16(5):1927–32. Epub 2006/10/03. https://doi.org/10.1111/j.1525-1438.2006.00661.x PMID: 17009993.
20. Frumovitz M, dos Reis R, Sun CC, Milam MR, Bevers MW, Brown J, et al. Comparison of total laparo-
scopic and abdominal radical hysterectomy for patients with early-stage cervical cancer. Obstetrics and
Gynecology. 2007; 110(1):96–102. https://doi.org/10.1097/01.AOG.0000268798.75353.04
WOS:000247572700016. PMID: 17601902
21. Li GY, Yan XJ, Shang HL, Wang G, Chen LS, Han YB. A comparison of laparoscopic radical hysterec-
tomy and pelvic lymphadenectomy and laparotomy in the treatment of Ib-IIa cervical cancer.

PLOS ONE | https://doi.org/10.1371/journal.pone.0253143 July 1, 2021 13 / 16


PLOS ONE Complications of surgical treatments for early-stage cervical cancer

Gynecologic Oncology. 2007; 105(1):176–80. https://doi.org/10.1016/j.ygyno.2006.11.011


WOS:000245559000027. PMID: 17197013
22. Uccella S, Laterza R, Ciravolo G, Volpi E, Franchi M, Zefiro F, et al. A comparison of urinary complica-
tions following total laparoscopic radical hysterectomy and laparoscopic pelvic lymphadenectomy to
open abdominal surgery. Gynecol Oncol. 2007; 107(1 Suppl 1):S147–9. Epub 2007/08/28. https://doi.
org/10.1016/j.ygyno.2007.07.027 PMID: 17720232.
23. Boggess JF, Gehrig PA, Cantrell L, Shafer A, Ridgway M, Skinner EN, et al. A case-control study of
robot-assisted type III radical hysterectomy with pelvic lymph node dissection compared with open radi-
cal hysterectomy. American Journal of Obstetrics and Gynecology. 2008; 199(4):357.e1–.e7. https://
doi.org/10.1016/j.ajog.2008.06.058 PMID: 18928973
24. Ko EM, Muto MG, Berkowitz RS, Feltmate CM. Robotic versus open radical hysterectomy: a compara-
tive study at a single institution. Gynecol Oncol. 2008; 111(3):425–30. Epub 2008/10/22. https://doi.org/
10.1016/j.ygyno.2008.08.016 PMID: 18929400.
25. Estape R, Lambrou N, Diaz R, Estape E, Dunkin N, Rivera A. A case matched analysis of robotic radical
hysterectomy with lymphadenectomy compared with laparoscopy and laparotomy. Gynecol Oncol.
2009; 113(3):357–61. Epub 2009/04/07. https://doi.org/10.1016/j.ygyno.2009.03.009 PMID: 19345987.
26. Maggioni A, Minig L, Zanagnolo V, Peiretti M, Sanguineti F, Bocciolone L, et al. Robotic approach for
cervical cancer: comparison with laparotomy: a case control study. Gynecol Oncol. 2009; 115(1):60–4.
Epub 2009/07/30. https://doi.org/10.1016/j.ygyno.2009.06.039 PMID: 19638333.
27. Malzoni M, Tinelli R, Cosentino F, Fusco A, Malzoni C. Total laparoscopic radical hysterectomy versus
abdominal radical hysterectomy with lymphadenectomy in patients with early cervical cancer: our expe-
rience. Ann Surg Oncol. 2009; 16(5):1316–23. Epub 2009/02/19. https://doi.org/10.1245/s10434-009-
0342-7 PMID: 19224286.
28. Papacharalabous E, Tailor A, Madhuri T, Giannopoulos T, Butler-Manuel S. Early experience of lapar-
oscopically assisted radical vaginal hysterectomy (Coelio-Schauta) versus abdominal radical hysterec-
tomy for early stage cervical cancer. Gynecological Surgery. 2009; 6(2):113–7. https://doi.org/10.1007/
s10397-008-0424-8
29. Sobiczewski P, Bidzinski M, Derlatka P, Panek G, Danska-Bidzinska A, Gmyrek L, et al. Early cervical
cancer managed by laparoscopy and conventional surgery: comparison of treatment results. Int J Gyne-
col Cancer. 2009; 19(8):1390–5. Epub 2009/12/17. https://doi.org/10.1111/IGC.0b013e3181ba5e88
PMID: 20009895.
30. Schreuder HW, Zweemer RP, van Baal WM, van de Lande J, Dijkstra JC, Verheijen RH. From open
radical hysterectomy to robot-assisted laparoscopic radical hysterectomy for early stage cervical can-
cer: aspects of a single institution learning curve. Gynecol Surg. 2010; 7(3):253–8. Epub 2010/08/12.
https://doi.org/10.1007/s10397-010-0572-5 PMID: 20700514.
31. Lee EJ, Kang H, Kim DH. A comparative study of laparoscopic radical hysterectomy with radical abdom-
inal hysterectomy for early-stage cervical cancer: a long-term follow-up study. European Journal of
Obstetrics & Gynecology and Reproductive Biology. 2011; 156(1):83–6. https://doi.org/10.1016/j.
ejogrb.2010.12.016 WOS:000291715600016. PMID: 21269754
32. Sert MB, Abeler V. Robot-assisted laparoscopic radical hysterectomy: comparison with total laparo-
scopic hysterectomy and abdominal radical hysterectomy; one surgeon’s experience at the Norwegian
Radium Hospital. Gynecol Oncol. 2011; 121(3):600–4. Epub 2011/03/01. https://doi.org/10.1016/j.
ygyno.2011.02.002 PMID: 21353294.
33. Taylor SE, McBee WC Jr., Richard SD, Edwards RP. Radical hysterectomy for early stage cervical can-
cer: laparoscopy versus laparotomy. Jsls. 2011; 15(2):213–7. Epub 2011/09/10. https://doi.org/10.
4293/108680811X13022985132218 PMID: 21902978.
34. Gortchev G, Tomov S, Tantchev L, Velkova A, Radionova Z. Robot-assisted radical hysterectomy-peri-
operative and survival outcomes in patients with cervical cancer compared to laparoscopic and open
radical surgery. Gynecological Surgery. 2012; 9(1):81–8. https://doi.org/10.1007/s10397-011-0683-7
35. Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH. Laparoscopic compared with open radical hyster-
ectomy in obese women with early-stage cervical cancer. Obstet Gynecol. 2012; 119(6):1201–9. Epub
2012/05/24. https://doi.org/10.1097/AOG.0b013e318256ccc5 PMID: 22617585.
36. Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH. Laparoscopic versus open radical hysterectomy
in patients with stage IB2 and IIA2 cervical cancer. J Surg Oncol. 2013; 108(1):63–9. Epub 2013/06/06.
https://doi.org/10.1002/jso.23347 PMID: 23737035.
37. Bogani G, Cromi A, Uccella S, Serati M, Casarin J, Pinelli C, et al. Laparoscopic versus open abdominal
management of cervical cancer: long-term results from a propensity-matched analysis. J Minim Inva-
sive Gynecol. 2014; 21(5):857–62. Epub 2014/04/05. https://doi.org/10.1016/j.jmig.2014.03.018 PMID:
24699300.

PLOS ONE | https://doi.org/10.1371/journal.pone.0253143 July 1, 2021 14 / 16


PLOS ONE Complications of surgical treatments for early-stage cervical cancer

38. Chen CH, Chiu LH, Chang CW, Yen YK, Huang YH, Liu WM. Comparing robotic surgery with conven-
tional laparoscopy and laparotomy for cervical cancer management. Int J Gynecol Cancer. 2014; 24
(6):1105–11. Epub 2014/06/14. https://doi.org/10.1097/IGC.0000000000000160 PMID: 24927245.
39. Yin XH, Wang ZQ, Yang SZ, Jia HY, Shi M. Clinical observation of laparoscopic radical hysterectomy
for cervical cancer. Int J Clin Exp Med. 2014; 7(5):1373–7. Epub 2014/07/06.PMID: 24995098.
40. Asciutto KC, Kalapotharakos G, Löfgren M, Högberg T, Borgfeldt C. Robot-assisted surgery in cervical
cancer patients reduces the time to normal activities of daily living. Acta Obstetricia et Gynecologica
Scandinavica. 2015; 94(3):260–5. https://doi.org/10.1111/aogs.12561 PMID: 25494915
41. Xiao M, Zhang Z. Total Laparoscopic Versus Laparotomic Radical Hysterectomy and Lymphadenect-
omy in Cervical Cancer: An Observational Study of 13-Year Experience. Medicine (Baltimore). 2015;
94(30):e1264. Epub 2015/07/30. https://doi.org/10.1097/MD.0000000000001264 PMID: 26222868.
42. Park JY, Kim D, Suh DS, Kim JH, Kim YM, Kim YT, et al. The Role of Laparoscopic Radical Hysterec-
tomy in Early-Stage Adenocarcinoma of the Uterine Cervix. Ann Surg Oncol. 2016; 23(Suppl 5):825–
33. Epub 2016/08/10. https://doi.org/10.1245/s10434-016-5489-4 PMID: 27503491.
43. Shah CA, Beck T, Liao JB, Giannakopoulos NV, Veljovich D, Paley P. Surgical and oncologic outcomes
after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early
cervical cancer. J Gynecol Oncol. 2017; 28(6):e82. Epub 2017/10/14. https://doi.org/10.3802/jgo.2017.
28.e82 PMID: 29027400.
44. Corrado G, Vizza E, Legge F, Pedone Anchora L, Sperduti I, Fagotti A, et al. Comparison of Different
Surgical Approaches for Stage IB1 Cervical Cancer Patients: A Multi-institution Study and a Review of
the Literature. Int J Gynecol Cancer. 2018; 28(5):1020–8. Epub 2018/05/05. https://doi.org/10.1097/
IGC.0000000000001254 PMID: 29727351.
45. Guo J, Yang L, Cai J, Xu L, Min J, Shen Y, et al. Laparoscopic procedure compared with open radical
hysterectomy with pelvic lymphadenectomy in early cervical cancer: a retrospective study. Onco Tar-
gets Ther. 2018; 11:5903–8. Epub 2018/10/03. https://doi.org/10.2147/OTT.S156064 PMID:
30271174.
46. Bogani G, Rossetti D, Ditto A, Martinelli F, Chiappa V, Leone C, et al. Minimally invasive surgery
improves short-term outcomes of nerve-sparing radical hysterectomy in patients with cervical cancer: a
propensity-matched analysis with open abdominal surgery. J Gynecol Oncol. 2019; 30(2):e27. Epub
2019/02/12. https://doi.org/10.3802/jgo.2019.30.e27PMID: 30740958.
47. Matanes E, Abitbol J, Kessous R, Kogan L, Octeau D, Lau S, et al. Oncologic and Surgical Outcomes
of Robotic Versus Open Radical Hysterectomy for Cervical Cancer. Journal of Obstetrics and Gynae-
cology Canada. 2019; 41(4):450–8. https://doi.org/10.1016/j.jogc.2018.09.013 PMID: 30529223
48. Piedimonte S, Czuzoj-Shulman N, Gotlieb W, Abenhaim HA. Robotic Radical Hysterectomy for Cervical
Cancer: A Population-Based Study of Adoption and Immediate Postoperative Outcomes in the United
States. J Minim Invasive Gynecol. 2019; 26(3):551–7. Epub 2018/09/09. https://doi.org/10.1016/j.jmig.
2018.08.012 PMID: 30195078.
49. Pahisa J, Martinez-Roman S, Torne A, Fuste P, Alonso I, Lejarcegui JA, et al. Comparative study of
laparoscopically assisted radical vaginal hysterectomy and open Wertheim-Meigs in patients with early-
stage cervical cancer: eleven years of experience. Int J Gynecol Cancer. 2010; 20(1):173–8. Epub
2010/02/05. https://doi.org/10.1111/IGC.0b013e3181bf80ee PMID: 20130519.
50. Morgan DJ, Hunter DC, McCracken G, McClelland HR, Price JH, Dobbs SP. Is laparoscopically assis-
ted radical vaginal hysterectomy for cervical carcinoma safe? A case control study with follow up. Bjog.
2007; 114(5):537–42. Epub 2007/03/16. https://doi.org/10.1111/j.1471-0528.2007.01291.x PMID:
17355358.
51. Zakashansky K, Chuang L, Gretz H, Nagarsheth NP, Rahaman J, Nezhat FR. A case-controlled study
of total laparoscopic radical hysterectomy with pelvic lymphadenectomy versus radical abdominal hys-
terectomy in a fellowship training program. International Journal of Gynecological Cancer. 2007; 17
(5):1075–82. https://doi.org/10.1111/j.1525-1438.2007.00921.x WOS:000249487500019. PMID:
17386041
52. Nam JH, Park JY, Kim DY, Kim JH, Kim YM, Kim YT. Laparoscopic versus open radical hysterectomy
in early-stage cervical cancer: long-term survival outcomes in a matched cohort study. Ann Oncol.
2012; 23(4):903–11. Epub 2011/08/16. https://doi.org/10.1093/annonc/mdr360 PMID: 21841155.
53. Ditto A, Martinelli F, Bogani G, Gasparri ML, Di Donato V, Zanaboni F, et al. Implementation of laparo-
scopic approach for type B radical hysterectomy: a comparison with open surgical operations. Eur J
Surg Oncol. 2015; 41(1):34–9. Epub 2014/12/04. https://doi.org/10.1016/j.ejso.2014.10.058 PMID:
25468458.
54. Yuan Z, Cao D, Yang J, Yu M, Shen K, Yang J, et al. Laparoscopic vs. Open Abdominal Radical Hyster-
ectomy for Cervical Cancer: A Single-Institution, Propensity Score Matching Study in China. Front
Oncol. 2019; 9:1107. Epub 2019/11/19. https://doi.org/10.3389/fonc.2019.01107 PMID: 31737563.

PLOS ONE | https://doi.org/10.1371/journal.pone.0253143 July 1, 2021 15 / 16


PLOS ONE Complications of surgical treatments for early-stage cervical cancer

55. Lee CL, Huang KG, Jain S, Lee PS, Soong YK. Comparison of laparoscopic and conventional surgery
in the treatment of early cervical cancer. J Am Assoc Gynecol Laparosc. 2002; 9(4):481–7. Epub 2002/
10/19. https://doi.org/10.1016/s1074-3804(05)60523-3 PMID: 12386360.
56. Lim YK, Chia YN, Yam KL. Total laparoscopic Wertheim’s radical hysterectomy versus Wertheim’s radi-
cal abdominal hysterectomy in the management of stage I cervical cancer in Singapore: a pilot study.
Singapore Med J. 2013; 54(12):683–8. Epub 2013/12/21. https://doi.org/10.11622/smedj.2013242
PMID: 24356754.
57. Campos LS, Limberger LF, Stein AT, Kalil AN. Postoperative pain and perioperative outcomes after lap-
aroscopic radical hysterectomy and abdominal radical hysterectomy in patients with early cervical can-
cer: a randomised controlled trial. Trials. 2013; 14. https://doi.org/10.1186/1745-6215-14-293
WOS:000325490500001. PMID: 24028441
58. Llarena NC, Shah AB, Milad MP. Bowel injury in gynecologic laparoscopy: a systematic review. Obstet
Gynecol. 2015 Jun; 125(6):1407–1417. https://doi.org/10.1097/AOG.0000000000000855 Erratum in:
Obstet Gynecol. 2015 Oct;126(4):903. PMID: 26000512.
59. van der Voort M, Heijnsdijk EA, Gouma DJ. Bowel injury as a complication of laparoscopy. Br J Surg.
2004 Oct; 91(10):1253–8. https://doi.org/10.1002/bjs.4716 PMID: 15376204.
60. Ott DE. Subcutaneous emphysema—beyond the pneumoperitoneum. JSLS. 2014 Jan-Mar; 18(1):1–7.
Erratum in: JSLS. 2016 Apr-Jun;20(2). pii: e2016.00050. https://doi.org/10.4293/
108680813X13693422520882 PMID: 24680136.
61. Liang C, Liu P, Cui Z, Liang Z, Bin X, Lang J, et al. Effect of laparoscopic versus abdominal radical hys-
terectomy on major surgical complications in women with stage IA-IIB cervical cancer in China, 2004–
2015. Gynecol Oncol. 2020; 156(1):115–23. Epub 2019/12/07. https://doi.org/10.1016/j.ygyno.2019.
10.032 PMID: 31806399.
62. Chong GO, Park NY, Hong DG, Cho YL, Park IS, Lee YS. Learning curve of laparoscopic radical hyster-
ectomy with pelvic and/or para-aortic lymphadenectomy in the early and locally advanced cervical can-
cer: comparison of the first 50 and second 50 cases. Int J Gynecol Cancer. 2009 Nov; 19(8):1459–64.
https://doi.org/10.1111/IGC.0b013e3181b76640 PMID: 20009907.
63. Yim GW, Kim SW, Nam EJ, Kim S, Kim YT. Learning curve analysis of robot-assisted radical hysterec-
tomy for cervical cancer: initial experience at a single institution. J Gynecol Oncol. 2013 Oct; 24(4):303–
12. https://doi.org/10.3802/jgo.2013.24.4.303 Epub 2013 Oct 2. PMID: 24167665.
64. Hwang JH. Urologic complication in laparoscopic radical hysterectomy: meta-analysis of 20 studies.
Eur J Cancer. 2012; 48(17):3177–85. Epub 2012/07/25. https://doi.org/10.1016/j.ejca.2012.06.006
PMID: 22824588.
65. Park DA, Yun JE, Kim SW, Lee SH. Surgical and clinical safety and effectiveness of robot-assisted lap-
aroscopic hysterectomy compared to conventional laparoscopy and laparotomy for cervical cancer: A
systematic review and meta-analysis. Eur J Surg Oncol. 2017; 43(6):994–1002. Epub 2016/08/23.
https://doi.org/10.1016/j.ejso.2016.07.017 PMID: 27546015.

PLOS ONE | https://doi.org/10.1371/journal.pone.0253143 July 1, 2021 16 / 16

You might also like